Ifosfamide combined with toremifene in the treatment of non-small cell lung cancer

被引:2
|
作者
Salomaa, ER [1 ]
Liippo, K [1 ]
Ellmen, J [1 ]
Komi, J [1 ]
机构
[1] ORION CORP FARMOS,FIN-20101 TURKU,FINLAND
关键词
non-small cell lung cancer; chemotherapy; multi-drug resistance; toremifene; ifosfamide;
D O I
10.1016/S0169-5002(96)00613-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The efficacy and safety of toremifene-ifosfamide as a first-line chemotherapy in non-small cell lung cancer were assessed. Sixteen patients were treated with oral toremifene (420 mg on days 1-4 and 240 mg on day 5) followed by ifosfamide infusion 5 g/m(2) on day 5 every 3 weeks 1-6 times. Toremifene at the doses used did not enhance the effect or toxicity of ifosfamide in previously untreated non-small cell lung cancer patients. Copyright (C) 1996 Elsevier Science Ireland Ltd.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 50 条
  • [1] IFOSFAMIDE IN THE TREATMENT OF NON-SMALL CELL LUNG-CANCER
    ETTINGER, DS
    SEMINARS IN ONCOLOGY, 1989, 16 (01) : 31 - 38
  • [2] Ifosfamide in non-small cell lung cancer
    Boni, C
    Zanelli, F
    ONCOLOGY, 2003, 65 : 50 - 54
  • [3] The role of ifosfamide in non-small cell lung cancer (NSCLC) treatment
    Manegold, K
    EXPERIMENTAL ONCOLOGY, 1996, 18 (01): : 69 - 72
  • [4] Ifosfamide and docetaxel in non-small cell lung cancer
    Drings, P
    Buchholz, E
    Manegold, C
    SEMINARS IN ONCOLOGY, 1998, 25 (01) : 29 - 37
  • [5] Ifosfamide in non-small cell lung
    Johnson, DH
    SEMINARS IN ONCOLOGY, 1996, 23 (03) : 7 - 10
  • [6] Vinorelbine and alternating cisplatin and ifosfamide in the treatment of non-small cell lung cancer
    Barone, C
    Corsi, DC
    Pozzo, C
    Cassano, A
    Alvaro, G
    Colloca, G
    Landriscina, M
    Astone, A
    ONCOLOGY, 2000, 58 (01) : 25 - 30
  • [7] IFOSFAMIDE BY BOLUS AS TREATMENT FOR ADVANCED NON-SMALL CELL LUNG-CANCER
    THATCHER, N
    ANDERSON, H
    SMITH, DB
    STEWARD, WP
    WEBB, K
    HILTON, A
    RAHMAN, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 : S30 - S33
  • [8] Ifosfamide and paclitaxel combinations for the treatment of advanced non-small cell lung cancer
    Shepherd, FA
    Eisenhauer, E
    SEMINARS IN ONCOLOGY, 1998, 25 (01) : 2 - 7
  • [9] Vinorelbine and ifosfamide for unresectable non-small cell lung cancer
    Morere, JF
    Pipernoneumann, S
    Brunet, A
    Boaziz, C
    Kohn, M
    Bouillet, T
    Breau, JL
    LUNG CANCER, 1997, 18 (01) : 95 - 100
  • [10] Endobronchial combined treatment of non-small cell lung cancer
    Cicenas, S
    Valuckas, K
    Aizenas, M
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 55 - 59